Search Results

Displaying Results 7301-7325 of 161331 "'ARE'"

Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TruGolf Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - TRUG

"Company") (NASDAQ: TRUG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address,

More news about: Pomerantz LLP


Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Avis Budget Group, Inc. - CAR

If you are an investor who purchased or otherwise acquired Avis securities (including if you bought Avis common stock to cover a short position) during the Class

More news about: Pomerantz LLP


Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AppLovin Corporation and Certain Officers - APP

If you are an investor who purchased or otherwise acquired AppLovin securities during the Class Period, you have until November 16, 2026 to ask the Court to appoint

More news about: Pomerantz LLP


Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AST SpaceMobile, Inc. and Certain Officers - ASTS

If you are an investor who purchased or otherwise acquired AST securities during the Class Period, you have until November 13, 2026 to ask the Court to appoint

More news about: Pomerantz LLP


Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT

If you are an investor who purchased or otherwise acquired Datavault AI securities during the Class Period, you have until October 5, 2026, to ask the Court to

More news about: Pomerantz LLP


Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers - GUTS

If you are an investor who purchased or otherwise acquired Fractyl securities during the Class Period, you have until October 20, 2026 to ask the Court to appoint

More news about: Pomerantz LLP


Sep 24, 2026, 17:37 ET Bluerock Acquisition Corp. II Announces Pricing of $150 Million Initial Public Offering

Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's offering filed with the SEC. Copies are available on the

More news about: Bluerock Acquisition Corp. II


Sep 24, 2026, 17:35 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lincoln Educational Services Corp. of Class Action Lawsuit and Upcoming Deadlines - LINC

"Company") (NASDAQ: LINC).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE

LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

Pomerantz LLP is investigating claims on behalf of investors of SELLAS Life Sciences Group, Inc. ("Sellas" or the "Company") (NASDAQ: SLS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Stryker Corp. ("Stryker" or the "Company") (NYSE: SYK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU

Pomerantz LLP is investigating claims on behalf of investors of lululemon athletica inc. ("lululemon" or the "Company") (NASDAQ: LULU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EyePoint, Inc. ("EyePoint" or the "Company") (NASDAQ: EYPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. ("OSI" or the "Company") (NASDAQ: OSIS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of L3Harris Technologies, Inc. - LHX

Pomerantz LLP is investigating claims on behalf of investors of L3Harris Technologies, Inc. ("L3Harris" or the "Company") (NYSE: LHX).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ: ABEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS

Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. ("AirSculpt" or the "Company") (NASDAQ: AIRS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. - SEDG

Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. ("SolarEdge" or the "Company") (NASDAQ: SEDG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Limited - EH

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Limited ("EHang" or the "Company") (NASDAQ: EH).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Beam Therapeutics Inc. ("Beam" or the "Company") (NASDAQ: BEAM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ

-- Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("Lenz" or the "Company") (NASDAQ: LENZ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION

Pomerantz LLP is investigating claims on behalf of investors of Sionna Therapeutics, Inc. ("Sionna" or the "Company") (NASDAQ: SION). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Klarna Group plc - KLAR

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Klarna Group plc ("Klarna" or the "Company") (NYSE: KLAR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of D-Wave Quantum Inc. - QBTS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of D-Wave Quantum Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,

More news about: Pomerantz LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.